Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IOWA PROSPECTIVE DUB DEMONSTRATION PROJECT IS GENERATING 8%- 10% RATE

Executive Summary

IOWA PROSPECTIVE DUB DEMONSTRATION PROJECT IS GENERATING 8%- 10% RATE of drug utilization review messages for pharmacies in its first five months. "For every 100 claims received, we are sending about 8-10 DUR messages back," University of Iowa Associate Professor of Preventive Medicine Betsy Chrischilles, PhD, reported. Providing an update on the 30-month project to the Zitter Group's Congress on Health Outcomes & Accountability in Washington on Dec. 13, Chrischilles noted that majority of messages in the first five months have related to early drug refills.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel